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Abstract
Background: Endoscopic submucosal dissection (ESD) permits removal of esophageal epithelial neoplasms en bloc,
but is associated with esophageal stenosis, particularly when ESD involves the entire circumference of the
esophageal lumen. We examined the effectiveness of systemic steroid administration for control of postprocedural
esophageal stricture after complete circular ESD.
Methods: Seven patients who underwent wholly circumferential ESD for superficially extended esophageal
squamous cell carcinoma were enrolled in this study. In 3 patients, prophylactic endoscopic balloon dilatation
(EBD) was started on the third post-ESD day and was performed twice a week for 8 weeks. In 4 patients, oral
prednisolone was started with 30 mg daily on the third post-ESD day, tapered gradually (daily 30, 30, 25, 25, 20, 15,
10, 5 mg for 7 days each), and then discontinued at 8 weeks. EBD was used as needed whenever patients
complained of dysphagia.
Results: En bloc ESD with tumor-free margins was safely achieved in all cases. Patients in the prophylactic EBD
group required a mean of 32.7 EBD sessions; the postprocedural stricture was dilated up to 18 mm in diameter in
these patients. On the other hand, systemic steroid administration substantially reduced or eliminated the need for
EBD. Corticosteroid therapy was not associated with any adverse events. Post-ESD esophageal stricture after
complete circular ESD was persistent, requiring multiple EBD sessions.
Conclusions: Use of oral prednisolone administration may be an effective treatment strategy for reducing post-
ESD esophageal stricture after complete circular ESD.
Background
Endoscopic submucosal dissection (ESD) was developed
to dissect directly along the submucosal layer for gastric
epithelial neoplasia [1,2]. ESD has an advantage over
endoscopic mucosal resection (EMR) for removing gas-
trointestinal tumors en bloc, regardless of their size
[1,2]. ESD allows precise histological assessment of the
specimens excised in one piece with tumor-free lateral/
basal margins, preventing residual disease and local
recurrence [2,3].
Several studies in advanced institutes showed that ESD
was promising for superficial esophageal epithelial neo-
plasms with nominal risks for nodal or distant metastasis
[4,5]. Nevertheless, a substantial risk of procedure-related
complications, including potentially life-threatening per-
foration and postprocedural stenosis, have been reported
[4]. Although the exact incidence of luminal stricture
after esophageal ESD is unknown, it is related to the
extent of the circumference being resected [6]. In parti-
cular, esophageal stricture occurs commonly following
ESD involving the entire circumference of the esophageal
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decreases patients’ quality of life (QOL), requiring multi-
ple sessions of endoscopic balloon dilatation (EBD) [7].
Although EBD has been a treatment of choice in the
setting of benign esophageal strictures [8], intralesional
steroid injection into corrosive or anastomotic strictures
can achieve remission of dysphagia or reduce the need
for repeated EBD [9,10]. However, certain patients with
recalcitrant esophageal stricture do not respond to local
steroid therapy, although systemic steroid administration
often resolves the problem in such cases [11,12]. We
report on 7 consecutive patients with superficial esopha-
geal squamous cell carcinoma (SCC) who underwent
wholly circumferential ESD. Among these patients, 4
were treated with an 8-week course of oral predniso-
lone, which effectively either prevented esophageal stric-
ture or reduced the number of EBD sessions.
Methods
Patients
A total of 7 patients (6 men, 1 woman; mean age, 68
years; range, 60-74 years) underwent complete circular
ESD for superficially extended SCC of the esophagus at
Nagasaki University Hospital. The clinicopathological
features of each patient are summarized in Table 1. The
Ethics Committee of Nagasaki University Hospital
approved this study, and written informed consent was
obtained from each patient. The tumor was demarked
using chromoendoscopy with iodine staining. Because
all superficial SCCs involved nearly the entire circumfer-
ence of the esophageal lumen, complete circular resec-
tion was considered necessary in each patient.
ESD
For the ESD procedure, a single-channel upper gastroin-
testinal endoscope with a water-jet system (GIF-Q260J,
Olympus Medical Systems, Tokyo, Japan) was used with
a transparent cap attached to the endoscope tip. Cir-
cumferential markings were made on the proximal and
distal sides of the normal-appearing mucosa at least
5 mm from the lesions. A high-frequency generator
(VIO300D; ERBE Elektromedizin GmbH, Tübingen,
Germany) was set at the forced coagulation mode
(Effect 2, output 40 W) to incise the mucosa. A ready-
to-use hyaluronic acid solution (MucoUp, Seikagaku
Co., Tokyo, Japan) was injected into the submucosal
layer to lift the surrounding mucosa. The distal mucosal
incision was completed first all the way around the
markings with the FlushKnife (Fujinon-Toshiba ES Sys-
tem Co, Omiya, Japan) under the Endo cut I mode
(Effect 4, Duration 2, Interval 3). The proximal mucosa
was then incised in the same circular fashion. The sub-
mucosa was incised using the FlushKnife under the
forced coagulation mode (Effect 2, output 40 W), start-
ing beneath the proximal mucosal incision in each
quadrant. The submucosal dissection was advanced to
reach the distal side of the mucosal incision, thus creat-
ing a submucosal tunnel. Then, the submucosa between
the 4 longitudinal tunnels was dissected to connect
together until the lesion was detached. To control bleed-
ing during ESD or to prevent possible bleeding from
visible vessels in the artificial ulcer immediately after
resection, a hemostatic forceps (Coagrasper, Olympus)
was used in the soft coagulation mode (Effect 5, 60 W).
Each patient was sedated by intravenous injection of
7.5 mg diazepam and 50 mg pethidine, and additional
diazepam (2.5 mg) or pethidine (25 mg) was given alter-
nately as needed for conscious sedation throughout
ESD. CO2 insufflation was used during the procedure.
Procedure-related bleeding after ESD was defined as
bleeding that required transfusion or surgical interven-
tion or bleeding that caused the hemoglobin level to fall
by 2 g/dL [13]. Procedure-related perforation was diag-
nosed endoscopically or by the presence of free air on a
plain chest X-ray and chest computed tomogram (CT)
[5]. Longitudinal diameter was measured from the oral
edge to the anal edge of resected specimens that were
stretched appropriately. The tumor longitudinal dia-
meter was also documented. Excised specimens were
fixed in 10% buffered formalin, paraffin-embedded,
Table 1 Clinicopathological features and treatment measures for esophageal stricture for 7 patients with esophageal
squamous cell carcinoma treated by complete circular endoscopic submucosal dissection
Case No. Age Endoscopic
morphology
Resection size
(mm)
Tumor size
(mm)
Thoracic location Depth of tumor invasion Treatment for stricture EBD times
1 73 IIc 43 40 Lower m2 Preemptive EBD 30
2 60 IIb 70 56 Middle sm1 Preemptive EBD 20
3 65 IIb 94 67 Middle m2 Preemptive EBD 48
4 72 IIb 70 70 Middle m2 Prednisolone 2
5 74 IIc 75 65 Middle m2 Prednisolone 0
6 66 IIb 81 58 Middle sm1 Prednisolone 11
7 65 IIc 80 65 Midddle m2 Prednisolone 0
m2, intramucosal invasive carcinoma limited to the lamina propria mucosae; sm1, slightly invasive carcinoma into the submucosa (<200 μm); EBD, endoscopic
balloon dilatation.
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with hematoxylin and eosin. En bloc resection refers to
resection in one-piece [14]. Follow-up endoscopy with
iodine staining and contrast-enhanced CT of the cervix,
thorax, and abdomen were scheduled at 3, 6, and
12 months after ESD and then annually thereafter.
Biopsy specimens during each follow-up endoscopy
were taken from any mucosal abnormalities to assess
the presence of local recurrent tumor.
Postprocedural esophageal strictures and management
Between June 2008 and September 2009, pre-emptive
EBD using a CRE balloon (Boston Scientific Co., Boston,
MA, USA) was started in 3 patients (Case No. 1-3,
Table 1) on the third post-ESD day and performed
twice a week for 8 weeks. The postprocedural stricture
was dilated up to 18 mm in diameter. In cases of persis-
tent dysphagia, EBD was performed until dysphagia
resolved. Since October 2009, oral prednisolone was
administered to 4 patients (Case No. 4-7, Table 1), start-
ing at a dose of 30 mg daily on the third post-ESD day,
tapered gradually (daily 30, 30, 25, 25, 20, 15, 10, 5 mg
for 7 days each), and then discontinued 8 weeks later.
EBD was applied as needed whenever the patients com-
plained of dysphagia.
Statistical analysis
The statistical significance of data was determined using
the Student’s t test. A P value less than 0.05 was consid-
ered statistically significant.
Results
As shown in Table 1, there were 4 IIb and 3 IIc macro-
scopic types in accordance with the Paris endoscopic
classification [15]. They were located in the middle (6)
and lower (1) thoracic esophagus. All lesions were
resected in an en bloc fashion and removed with tumor-
f r e el a t e r a la n db a s a lm a r g i ns. There was no procedure-
related bleeding or perforation. The mean operation time
was 163 minutes (range, 100 to 260 minutes). The overall
longitudinal diameter of resected specimens was 73.3
mm (range, 43 to 94 mm). The overall mean longitudinal
diameter of the excised tumors was 60.1 mm (range, 40
to 70 mm). As for tumor invasion depth, there were
5 m2 lesions (intramucosal invasive carcinoma limited to
the lamina propria mucosae) and 2 sm1 lesions (slightly
invasive carcinoma into the submucosa (<200 μm) that
were well-differentiated SCC with expanding tumor
growth lacking angiolymphatic invasion. The 2 patients
with submucosally invasive SCC underwent chemoradia-
tion, and local recurrence and distant metastasis were
not observed on a systemic CT scan 7 and 20 months
later. All patients were still alive during the mean follow-
up period of 11 months (range, 5 to 22 months).
In the prophylactic EBD group, postprocedural stric-
ture accompanied by dysphagia occurred in all 3
patients. These patients required multiple EBD sessions
(mean 32.7 sessions, Table 1). In particular, Case 3
required 48 sessions to relieve his dysphagia (Figure 1).
On the other hand, the 4 patients who received 8-week
systemic steroid treatment required fewer EBD sessions
(Table 1). There was a significant difference in the num-
ber of required EBD sessions between the two treatment
groups (p < 0.05, Student’s t test). There were 2 patients
who did not experience luminal stricture and dysphagia;
thus, EBD was not done in all patients who received
steroid therapy (Figure 2). No adverse events related to
oral prednisolone administration were seen in any
patient.
Discussion
Esophageal ESD is associated with a substantial risk of
complications [4,5]. Because relatively large superficial
esophageal epithelial neoplasms are candidates for this
procedure, postoperative stricture has become a major
concern with regard to long-term clinical outcome [6].
Esophageal strictures can cause dysphagia and result in
decreased QOL or aspiration pneumonia [3]. Once the
patient has started to experience dysphagia due to eso-
phageal stricture, endoscopic dilatation with either a
bougie or a balloon (EBD) is the preferred mode of
treatment irrespective of the etiology [8]. Ono et al.
reported that post-ESD stricture with dysphagia was
successfully managed with EBD in a median of 2 ses-
sions [6]. Again, repetitive, periodic EBD was effective in
controlling and preventing postprocedural stricture even
after semicircular esophageal ESD [7]. However, a subset
of patients with esophageal stricture do not achieve
symptomatic relief despite repeated EBD. Compared
with peptic stricture, corrosive stricture may be long,
tortuous, and even multiple. Furthermore, corrosive
strictures may require more esophageal dilatation ses-
sions, which are often prolonged; these type of strictures
are also more likely to recur [16]. Radiation-induced
stricture also falls in the treatment-resistant category
[17]. Our experience with the current series indicates
that complete circular ESD for extended esophageal
SCC can cause persistent esophageal stricture. Indeed,
pre-emptive EBD was started on the third post-ESD day
and repeated twice a week for no less than 2 months,
but each patient required multiple EBD sessions due to
persistent dysphagia.
There are other ways to treat esophageal stenosis,
such as temporary stent insertion and local corticoster-
oid injection [9,18]. Prior studies suggest the usefulness
of intralesional steroid injection into benign esophageal
strictures for augmentation of the effects of endoscopic
dilatation [9,10]. However, there are some cases with
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Figure 1 In Case 3, complete circular endoscopic submucosal dissection (ESD) was achieved, and endoscopic balloon dilatation (EBD)
was performed preemptively. Nevertheless, he required total 48 sessions to relieve his dysphagia. A. Chromoendoscopy with an iodine
solution reveals the iodine-unstained area spreading to involve nearly the entire circumference of the esophagus (Case 3, Table 1). Wholly
circumferential ESD was performed. B. Artificial ulcer immediately after complete circular resection. C. The tumor was removed en bloc with
tumor-free lateral and basal margins, and histopathological assessment revealed intramucosal invasive squamous cell carcinoma (m2). Repeat
esophagoscopy revealed persistent esophageal stricture (D) despite 16 sessions (twice a week, for 8 weeks) of EBD (E), which was started on the
third postoperative day. Temporary improvement of the stricture was achieved with EBD (F), but this patient required 48 EBD sessions.
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Figure 2 In Case 5, complete circular ESD was achieved, and oral prednisolone was given. He has not required any EBD sessions without
no postprocedural stricture and the related dysphagia. A. Chromoendoscopy with iodine staining revealed a discolored area spreading to
involve nearly the entire circumference of the esophagus in the middle thoracic esophagus (Case 5, Table 1), and wholly circumferential,
endoscopic submucosal dissection was performed. B. Artificial ulcer immediately after complete circular resection. Complete circular resection
was achieved (C), and the tumor was removed en bloc with tumor-free lateral and basal margins (D). Histopathological assessment revealed
intramucosal invasive squamous cell carcinoma (m2). Oral prednisolone (30 mg) was initiated on the third postoperative day, tapered, and then
discontinued 8 weeks later. E. Follow-up endoscopy 6 months later revealed no postprocedural stricture without EBD.
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steroid injection followed by endoscopic dilatation
[11,12]. In addition, potential risks for esophageal per-
foration and mediastinitis or pleural effusion are asso-
ciated with local therapy [10]. It would be riskier when
injecting directly onto the ulcer bed immediately after
esophageal ESD. Recently, Morikawa et al. described
several cases with persistent esophageal stricture that
were resistant to intralesional steroid injection but were
successfully managed by systemic steroid administration
[11]. Similarly, there was a case report on successful
treatment of severe refractory anastomotic stricture after
esophageal atresia repair by EBD combined with sys-
temic steroid administration [12]. There could also be a
risk of esophageal candidiasis, inasmuch as there is a
propensity for this in stenotic esophageal lesions; corti-
costeroid administration could further increase the risk
[10].
In the present study, 4 patients were given oral pre-
dnisolone, which was effective in controlling postproce-
dural stricture and preventing repeat EBD. It was
started at a relatively moderate dosage of 30 mg and
continued for only 8 weeks. Accordingly, the total corti-
costeroid dose was nealy 1000 mg for the treatment
course, and there were no adverse events. The underly-
ing mechanisms whereby systemic prednisolone may
control post-ESD stricture and reduce EBD sessions
remain unclear. Corticosteroids can inhibit not only col-
lagen synthesis but also enhance collagen breakdown,
thereby inhibiting stricture formation [10]. It is postu-
lated that triamcinolone can prevent the cross-linking of
collagen that results in scar stricture [19]. Recently, eso-
phageal strictures have been managed using new tech-
nologies, such as biodegradable stents [18] or
autologous oral mucosal sheets [20]. However, until
these methods are available in the clinical setting, our
experience with systemic prednisolone administration
for complete circular ESD may thus offer an alternative
option to decrease the risk of benign esophageal stric-
tures and reduce the number of EBD sessions.
Conclusions
Complete circular esophageal ESD was safely and suc-
cessfully achieved in our small series with superficially
extended SCC. Oral prednisolone administration, but
not prophylactic EBD alone, was effective in controlling
the post-ESD stricture and in preventing repeated EBD
even after complete circular ESD. Further evaluation in
a larger series is needed before this therapeutic option
can be widely accepted.
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